Mips AB/Skr MIPS

1D1W1MYTD1Y5YMAX

About Mips AB

Mips AB is a Swedish company that operates within the safety products industry, with a focus on helmet-based safety and brain protection solutions. The company is renowned for its MIPS Brain Protection System, a technology integrated into helmets to reduce rotational motion transferred to the brain during impacts, which can significantly reduce the risk of certain brain injuries. Founded in 2001, Mips AB stems from research conducted at the Royal Institute of Technology and the Karolinska Institute in Stockholm. Headquartered in Stockholm, Sweden, the company has established itself with a strong geographic presence primarily through partnerships with helmet manufacturers worldwide. Mips AB's competitive strength lies in its proprietary technology and its ability to integrate seamlessly into diverse helmet types used in sports, motorcycling, and construction, among other areas.
Ticker
Skr MIPS
Primary listing
XSTO
Employees
127
Headquarters
Täby, Sweden

Mips AB Metrics

BasicAdvanced
kr 9.7B
58.73
kr 6.23
1.59
kr 2.50
0.68%

Bulls say / Bears say

Strong organic growth accelerated to 42% in Q2 2026, driving net sales up 72% to SEK 232 million and reflecting consistent market share gains across all segments (Investing.com).
Adjusted EBIT margin expanded to 46.7% in Q2 2026, up from 40.4% a year earlier, demonstrating the scalability of Mips’ business model and effective cost leverage (Investing.com).
The acquisition of Koroyd has integrated well, contributing 30% growth in Q2 and broadening Mips’ portfolio into safety, body protection, and gloves, positioning the company for expansion into adjacent markets (Mips Q2 report).
At a P/E ratio of 68.35, Mips’ valuation implies high earnings expectations, leaving limited margin for error should growth moderate or operational challenges arise (Investing.com).
Currency fluctuations weighed on reported results, with FX headwinds reducing first-half revenue by 7% and posing a recurring risk to growth metrics (Mips Q2 report).
The USD 3.25 million settlement of the patent infringement litigation with BrainGuard will impact Q3 EBIT and underscores the ongoing risk and cost of IP disputes (Omni.se).
Data summarised monthly by Lightyear AI. Last updated on 31 Aug 2026.

Funds containing Mips AB

AllEURGBPUSD
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.